Full name
"SSS CLINICAL RESEARCH POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ" W LIKWIDACJI
uses securityreCAPTCHA
"SSS CLINICAL RESEARCH POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ" W LIKWIDACJI
UL. BUFOROWA 4E / 8, 52-131 WROCŁAW
TAX ID8971747562
Rate company:
"SSS CLINICAL RESEARCH POLSKA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ" W LIKWIDACJI
TAX ID8971747562
KRS0000317113
address
UL. BUFOROWA 4E / 8, 52-131 WROCŁAW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
8971747562
REGON
02082869200000
KRS
0000317113
Legal form
limited liability company
Register Address
UL. BUFOROWA 4E / 8, 52-131 WROCŁAW
Date of registration in KRS
2008-11-03
Date of commencement of economic activity
2008-11-03
Act signature
WR.VI NS-REJ.KRS/12755/25/483
Pkd codes
72.19.Z - Scientific research and development activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
Payer VAT status
Unregirestered
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 30,2 | -36,1 | -48,7 | -34,8 |
EBITDA | 41 | -27,8 | -45,6 | -64,1 |
Short time liabilities | 17,8 | 7,1 | 6,6 | -6,5 |
Equity capital | 106,4 | 70,3 | 21,6 | -69,3 |
Operating profit (EBIT) | 41 | -27,8 | -45,6 | -64,1 |
Assets | 124,2 | 77,4 | 28,2 | -63,5 |
Net profit (loss) | 27,3 | -36,1 | -48,7 | -34,8 |
Cash | 121,9 | 74,4 | 26,1 | -64,9 |
Net income from sale | 252,1 | 172,3 | 0 | -100 |
Liabilities and provisions for liabilities | 17,8 | 7,1 | 6,6 | -6,5 |
Working assets | 124,2 | 77,4 | 28,2 | -63,5 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 25,6 | -51,4 | -225,3 | -173,9 |
Equity capital to total assets | 85,7 | 94,5 | 76,5 | -18 |
Gross profit margin | 12 | -21 | -33 | |
EBITDA Margin | 16,2 | -16,1 | -32,3 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 26 | 15 | 2 147 483 648 | 2 147 483 633 |
Current financial liquidity indicator | 6.970401287078857 | 10.908321380615234 | 4.2561211585998535 | -6,6 |
Net dept to EBITDA | -2.975844621658325 | 2.67423152923584 | 0.5723541975021362 | -2,1 |
Financial statements
11-04-2024 - 31-12-2024
Resolution on profit distribution or loss coverage
Download pdf11-04-2024 - 31-12-2024
Resolution or decision approving the annual financial statements
Download pdf11-04-2024 - 31-12-2024
Activity report
Download pdf11-04-2024 - 31-12-2024
Annual financial report
Download xml11-04-2024 - 31-12-2024
Annual financial report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
FUNDACJA FUTURES LITERACY POLSKA
WARSZAWA
4OpenMind
Białystok